AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|AAPL347.86-0.37 (-0.10%) ▼|ABBV285.28+0.09 (+0.03%) ▲|ABT102.99+0.48 (+0.47%) ▲|ACN247.30-11.44 (-4.42%) ▼|ADBE264.70-5.85 (-2.16%) ▼|AMAT382.35+6.77 (+1.80%) ▲|AMD518.40+10.47 (+2.06%) ▲|AMGN442.41-4.87 (-1.09%) ▼|AMT189.80+8.23 (+4.53%) ▲|AMZN249.56-0.82 (-0.33%) ▼|AVGO325.34+2.10 (+0.65%) ▲|AXP313.32-11.85 (-3.64%) ▼|BA186.84-0.72 (-0.38%) ▼|BAC50.79-0.29 (-0.57%) ▼|BKNG156.79-4.31 (-2.68%) ▼|BLK1,121.03-16.26 (-1.43%) ▼|BMY61.73-1.27 (-2.02%) ▼|BNY145.21-0.12 (-0.08%) ▼|BRK-B544.61-2.36 (-0.43%) ▼|C121.01-1.50 (-1.22%) ▼|CAT689.05-15.00 (-2.13%) ▼|CL94.15-3.24 (-3.33%) ▼|CMCSA22.71-0.14 (-0.59%) ▼|COF201.07-2.36 (-1.16%) ▼|COP152.43+6.80 (+4.67%) ▲|COST1,007.27-10.94 (-1.07%) ▼|CRM245.43-4.86 (-1.94%) ▼|CSCO106.52+1.63 (+1.55%) ▲|CVS93.67-0.81 (-0.86%) ▼|CVX232.96+6.28 (+2.77%) ▲|DE645.04+1.42 (+0.22%) ▲|DHR225.92-3.84 (-1.67%) ▼|DIS112.79-0.34 (-0.30%) ▼|DUK124.61-0.79 (-0.63%) ▼|EMR161.41+1.12 (+0.70%) ▲|FDX298.81-5.11 (-1.68%) ▼|GD348.42-2.38 (-0.68%) ▼|GE286.43-7.11 (-2.42%) ▼|GEV825.86-1.57 (-0.19%) ▼|GILD156.94-0.25 (-0.16%) ▼|GM75.54-1.67 (-2.16%) ▼|GOOG320.45-0.31 (-0.10%) ▼|GOOGL323.61-0.62 (-0.19%) ▼|GS885.04-6.26 (-0.70%) ▼|HD319.01-8.72 (-2.66%) ▼|HON219.15+0.84 (+0.38%) ▲|IBM252.62+0.51 (+0.20%) ▲|INTC87.06+1.57 (+1.84%) ▲|INTU345.79-9.11 (-2.57%) ▼|ISRG456.87+13.02 (+2.93%) ▲|JNJ262.87-4.75 (-1.77%) ▼|JPM332.01-4.53 (-1.35%) ▼|KO93.28-2.07 (-2.17%) ▼|LIN510.41+0.05 (+0.01%) ▲|LLY1,282.45-24.24 (-1.86%) ▼|LMT597.36+7.45 (+1.26%) ▲|LOW198.63-5.75 (-2.81%) ▼|LRCX233.12+2.97 (+1.29%) ▲|MA622.00-11.22 (-1.77%) ▼|MCD247.86-4.77 (-1.89%) ▼|MDLZ63.63-1.56 (-2.39%) ▼|MDT96.12-0.47 (-0.49%) ▼|META645.93-2.92 (-0.45%) ▼|MMM174.02-1.54 (-0.88%) ▼|MO74.96-1.11 (-1.46%) ▼|MRK144.97-2.27 (-1.54%) ▼|MS181.42-2.55 (-1.39%) ▼|MSFT524.63+3.55 (+0.68%) ▲|MU885.55+29.06 (+3.39%) ▲|NEE81.90-0.01 (-0.01%) ▼|NFLX67.02-0.04 (-0.05%) ▼|NKE37.68-0.65 (-1.68%) ▼|NOW156.83-0.17 (-0.11%) ▼|NVDA212.30+0.09 (+0.04%) ▲|ORCL127.44+1.90 (+1.51%) ▲|PEP135.08-3.75 (-2.70%) ▼|PFE30.10-0.33 (-1.07%) ▼|PG161.17-3.34 (-2.03%) ▼|PLTR195.88-0.32 (-0.16%) ▼|PM200.57-1.17 (-0.58%) ▼|QCOM174.86+2.03 (+1.17%) ▲|RTX191.21-3.50 (-1.80%) ▼|SBUX101.04-0.87 (-0.85%) ▼|SCHW90.24-1.20 (-1.31%) ▼|SO93.12-0.70 (-0.75%) ▼|SPG211.38-0.67 (-0.31%) ▼|T21.47-1.28 (-5.61%) ▼|TMO667.19-9.36 (-1.38%) ▼|TMUS150.15-8.64 (-5.44%) ▼|TSLA372.04-2.54 (-0.68%) ▼|TXN285.04+5.54 (+1.98%) ▲|UBER67.84-1.23 (-1.78%) ▼|UNH423.36-1.63 (-0.38%) ▼|UNP293.49-4.60 (-1.54%) ▼|UPS100.67-0.86 (-0.84%) ▼|USB59.61-0.42 (-0.69%) ▼|V408.98-5.36 (-1.29%) ▼|VZ44.57-0.64 (-1.40%) ▼|WFC82.45-0.56 (-0.67%) ▼|WMT119.96-1.16 (-0.96%) ▼|XOM183.02+4.79 (+2.69%) ▲|
13.2 C
New York
Friday, October 23, 2026

Tag: control

newsFORsourcecompanycontentinformation1releasesmarket

ABRDN INCOME CREDIT STRATEGIES FUND ANNOUNCES “AT-THE-MARKET” EQUITY OFFERING PROGRAM

PHILADELPHIA, Aug. 1, 2025 /PRNewswire/ -- abrdn Income Credit Strategies Fund (NYSE: ACP) (the "Fund"), a closed-end fund, has announced that it filed with...

SUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2025 DIVIDENDS

AUSTIN, Texas, Aug. 1, 2025 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized,...

LMT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Lockheed Martin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action...

SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), have until September 26, 2025 to seek appointment as lead plaintiff of the Lockheed Martin class action lawsuit. Captioned Khan v. Lockheed Martin Corporation, No. 25-cv-06197 (S.D.N.Y.), the Lockheed Martin class action lawsuit charges Lockheed Martin and certain of Lockheed Martin’s top current and former executives with violations of the Securities Exchange Act of 1934.

BEACH ENERGY’S Q4 ACTIVITIES REPORT

Trading Symbol: NWX (TSX-V) VANCOUVER, BC, Aug. 1, 2025 /CNW/ - Newport Exploration Ltd ("Newport" or "the Company") provides an update for licences in the...

JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

BOSTON, Aug. 1, 2025 /PRNewswire/ - The John Hancock closed-end funds listed below declared their monthly distributions today as follows: Declaration Date:         August 1, 2025...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Aug. 1, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the...

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program.

Edimakor V4.2.0 Ignites a New Era of AI Video Creation Powered by Google Veo 3

NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Edimakor, the trusted AI-powered video editing platform for creators around the world, has officially launched Version 4.2.0, bringing...

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

KENNESAW, Ga., Aug. 1, 2025 /CNW/ -- Automated Logic – Canada, Ltd. (ALC), a leading provider of innovative building-management solutions and a part of Carrier...

Automated Logic Completes Acquisition of Control Solutions, Ltd. Establishing First Field Office in British Columbia

KENNESAW, Ga., Aug. 1, 2025 /PRNewswire/ -- Automated Logic – Canada, Ltd. (ALC), a leading provider of innovative building-management solutions and a part of Carrier...

NIIMBL Announces Project Call 9.1 – New Funding Available for Biopharma Innovation

NEWARK, Del., Aug. 1, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce Project Call 9.1 for...

DeFi Development Corp. to Host X Spaces Event: “July 2025 Business Recap & AMA”

BOCA RATON, FL, Aug. 01, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, titled “July 2025 Business Recap & AMA.”

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsControl

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers